The familiar underlying problem is that Big Pharma is cash-rich but innovation-poor, so it has resorted to buying in bright ideas while it tries to overhaul its business model.
Innovation is poor; half of China's patents come from foreign companies.
The Chancellor identified the short-term, disengaged attitude of British institutional investors as a major cause of low business innovation and poor company performance - and set up a review under Paul Myners, head of the investment management company Gartmore and chairman of the Guardian Media Group (which owns The Observer).
"What jiggery-pokery is going on underneath this proposal, because it smacks of political interference and surgical jealousies?" Dr Gillian Halley, an RBHT pediatrician, claims the review process is "fundamentally flawed" and wants access, so far denied, to the hard evidence used to score the hospital's research and innovation as "poor".
For years we have tolerated the manipulation of data formats to maintain a monopoly that has imposed all sorts of costs of society, in terms of high prices, lack of innovation and poor quality software.
"Customers of mobile wireless telecommunications services likely will face higher prices, less product variety and innovation, and poorer quality services due to reduced incentives to invest than would exist absent the merger".
"Thus, unless this acquisition is enjoined, customers of mobile wireless telecommunications services likely will face higher prices, less product variety and innovation, and poorer quality services due to reduced incentives to invest than would exist absent the merger".
Too often, European politicians have tried to bring research and innovation to poorer parts of the continent in an attempt to draw employment to those areas, he says a strategy that's not likely to work.
This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries.
For instance, in a globalized economy, relatively rich nations will experience faster rates of diminishing returns on freely traded means of production, technologies, and innovations, than poorer countries.
